Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MARTIN & LEMIS AGAR W/VCAT INHIBITOR

K-Number: K823309 · 1982-12-03

ApplicantTroy Biologicals, Inc.
Decision Date1982-12-03
Product CodeJTY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MARTIN & LEMIS AGAR W/VCAT INHIBITOR is the device name listed in this FDA 510(k) record. The listed applicant is Troy Biologicals, Inc.. It received FDA 510(k) clearance on 1982-12-03 under 510(k) number K823309. The device is classified under product code JTY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MARTIN & LEMIS AGAR W/VCAT INHIBITOR?

MARTIN & LEMIS AGAR W/VCAT INHIBITOR is a medical device that received FDA 510(k) clearance on 1982-12-03. The listed applicant is Troy Biologicals, Inc.. The 510(k) number is K823309.

When did MARTIN & LEMIS AGAR W/VCAT INHIBITOR receive FDA 510(k) clearance?

MARTIN & LEMIS AGAR W/VCAT INHIBITOR received FDA 510(k) clearance on 1982-12-03, under 510(k) number K823309.

Who is the listed applicant for MARTIN & LEMIS AGAR W/VCAT INHIBITOR?

The FDA 510(k) record lists Troy Biologicals, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MARTIN & LEMIS AGAR W/VCAT INHIBITOR?

The FDA product code for MARTIN & LEMIS AGAR W/VCAT INHIBITOR is JTY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Troy Biologicals, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K861301BACTI PLATE (DERMATOLOGY) PRODUCT NO. PS-5000K832860SXT BLOOD AGARK832861SABOURAUD DEXTROSE AGARK832862TRANSGROW MEDIUMK832863STREP ID QUADK823310STREPTOCOCCUS SELECTIVE AGAR

View all 12 devices →

Related Devices (Code: JTY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K210511InTray GCBiomed Diagnostics IncorporatedK993033INTRAY GCBiomed Diagnostics, Inc.K954986GC BASE W/ 1% GCHIRemel, L.P.K950196CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIABioclinical Systems, Inc.K933122MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGARBioclinical Systems, Inc.K933121MICROBIOLOGICAL CULTURE MEDIA,CHOCOLATE AGARBioclinical Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑